Healthcare >> CEO Interviews >> August 20, 2007

Harry S. Palmin – Novelos Therapeutics, Inc. (nvlt)

TWST: What is Novelos Therapeutics?

Mr. Palmin: Novelos Therapeutics is in a pivotal Phase III trial for lung cancer

under SPA and Fast Track. We have several Phase IIs that are also ongoing